Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection

Pharmacological Research

Volumn 97, Issue , 2015, Pages 84-103

  García Niño, Wylly Ramsés ^a   Zazueta, Cecilia ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Ellagic acid; Liver protection; Molecular targets; Pharmacological activities

Indexed keywords

ALCOHOL; CARBON TETRACHLORIDE; CISPLATIN; CONCANAVALIN A; CYCLOSPORIN A; ELLAGIC ACID; FREE RADICAL; GALACTOSAMINE; ISONIAZID; LIPOPOLYSACCHARIDE; MERCURY; PARACETAMOL; RIFAMPICIN; TRACE ELEMENT; ANTIVIRUS AGENT; PROTECTIVE AGENT;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CELL ACTIVATION; CELL CYCLE; CELL PROLIFERATION; CELLULAR IMMUNITY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; ENZYME REGULATION; FATTY LIVER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNOMODULATION; INTRAHEPATIC CHOLESTASIS; LIPID DEGRADATION; LIPOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER PROTECTION; LIVER TOXICITY; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STELLATE CELL; VIRUS REPLICATION; ANIMAL; CHEMISTRY; CHOLESTASIS; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; HEPATITIS VIRUS; LIVER NEOPLASMS;

ANIMALS; ANTIVIRAL AGENTS; CHOLESTASIS; DRUG-INDUCED LIVER INJURY; ELLAGIC ACID; FATTY LIVER; HEPATIC STELLATE CELLS; HEPATITIS VIRUSES; HUMANS; LIVER NEOPLASMS; PROTECTIVE AGENTS;

EID: 84929167613     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.04.008     Document Type: Review

References (411)

1. L. Sibulesky Normal liver anatomy Clin. Liver Dis. 2 2013 S1 S3 10.1002/cld.124
2. Z. Kmieć Cooperation of liver cells in health and disease Adv. Anat. Embryol. Cell Biol. 161 2001 1 151
3. G. Ramadori, F. Moriconi, I. Malik, and J. Dudas Physiology and pathophysiology of liver inflammation, damage and repair J. Physiol. Pharmacol. 59 2008 107 117
4. J.W. Grisham Organizational principles of the liver I.M. Arias, H.J. Alter, J.L. Boyer, The Liver: Biology and Pathobiology 2009 Wiley-Blackwell Singapore 3 15
5. A. Singh, T.K. Bhat, and O.P. Sharma Clinical biochemistry of hepatotoxicity J. Clin. Toxicol. 4 2011 1 19 10.4172/2161-0495.S4-001
6. H. Cichoz-Lach, and A. Michalak Oxidative stress as a crucial factor in liver diseases World J. Gastroenterol. 20 2014 8082 8091 10.3748/wjg.v20.i25.8082
7. G. Tell, C. Vascotto, and C. Tiribelli Alterations in the redox state and liver damage: hints from the EASL Basic School of Hepatology J. Hepatol. 58 2013 365 374 10.1016/j.jhep.2012.09.018
8. R. Kohen, and A. Nyska Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification Toxicol. Pathol. 30 2002 620 650 10.1080/0192623029016672
9. E. Bursal, E. Köksal, and I. Gülçin Antioxidant activity and polyphenol content of cherry stem (Cerasus avium L.) determined by LC-MS/MS Food Res. Int. 51 2013 66 74 10.1016/j.foodres.2012.11.022
10. E. Bursal, and I. Gülçin Polyphenol contents and in vitro antioxidant activities of lyophilised aqueous extract of kiwifruit (Actinidia deliciosa) Food Res. Int. 44 2011 1482 1489 10.1016/j.foodres.2011.03.031
11. I. Gulcin, and S. Beydemir Phenolic compounds as antioxidants: carbonic anhydrase isoenzymes inhibitors Mini Rev. Med. Chem. 13 2013 408 430
12. I. Gülçin Antioxidant activity of food constituents: an overview Arch. Toxicol. 86 2012 345 391 10.1007/s00204-011-0774-2
13. D.E. Stevenson, and R.D. Hurst Polyphenolic phytochemicals - just antioxidants or much more? Cell. Mol. Life Sci. 64 2007 2900 2916 10.1007/s00018-007-7237-1
14. A.R. Ndhlala, M. Moyo, and J. Van Staden Natural antioxidants: fascinating or mythical biomolecules? Molecules 15 2010 6905 6930 10.3390/molecules15106905
15. W.R. García-Niño, and J. Pedraza-Chaverrí Protective effect of curcumin against heavy metals-induced liver damage Food Chem. Toxicol. 69 2014 182 201 10.1016/j.fct.2014.04.016
16. S.P. Thyagarajan, S. Jayaram, and V. Gopalakrishnan Herbal medicines for liver diseases in India J. Gastroenterol. Hepatol. 17 2002 S370 S376
17. C. Girish, and S.C. Pradhan Indian herbal medicines in the treatment of liver diseases: problems and promises Fundam. Clin. Pharmacol. 26 2012 180 189 10.1111/j.1472-8206.2011.01011.x
18. M. Zafarullah, W.Q. Li, J. Sylvester, and M. Ahmad Molecular mechanisms of N-acetylcysteine actions Cell. Mol. Life Sci. 60 2003 6 20
19. P. Vitaglione, F. Morisco, N. Caporaso, and V. Fogliano Dietary antioxidant compounds and liver health Crit. Rev. Food Sci. Nutr. 44 2004 575 586
20. P. Malini, G. Kanchana, and M. Rajadurai Antibiabetic efficacy of allagic acid instreptozotocin induced diabetes mellitus in albino wistar rats Asian J. Pharm. Clin. Res. 4 2011 127 128
21. G. Grasser Synthetic Tannins. Their Synthesis, Industrial Production and Application 1922 Crosby Lockwood and Son London vi+143
22. L. Sepúlveda, A. Ascacio, and R. Rodríguez-Herrera Ellagic acid: biological properties and biotechnological development for production processes Afr. J. Biotechnol. 10 2011 4518 4523 10.5897/AJB10.2201
23. Y. Soong, and P.J. Barlow Quantification of gallic acid and ellagic acid from longan (Dimocarpus longan Lour.) seed and mango (Mangifera indica L.) kernel and their effects on antioxidant activity Food Chem. 97 2006 524 530 10.1016/j.foodchem.2005.05.033
24. G. Türk, M. Sönmez, and A.O. Ceribaşi Attenuation of cyclosporine A-induced testicular and spermatozoal damages associated with oxidative stress by ellagic acid Int. Immunopharmacol. 10 2010 177 182 10.1016/j.intimp.2009.10.013
25. N. Plundrich, M.H. Grace, I. Raskin, and M. Ann Lila Bioactive polyphenols from muscadine grape and blackcurrant stably concentrated onto protein-rich matrices for topical applications Int. J. Cosmet. Sci. 35 2013 394 401 10.1111/ics.12057
26. P. Truchado, M. Larrosa, and M.T. García-Conesa Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans J. Agric. Food Chem. 60 2012 5749 5754 10.1021/jf203641r
27. J.C. Espín, R. González-Barrio, and B. Cerdá Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans J. Agric. Food Chem. 55 2007 10476 10485 10.1021/jf0723864
28. G. Borges, S. Roowi, and J.M. Rouanet The bioavailability of raspberry anthocyanins and ellagitannins in rats Mol. Nutr. Food Res. 51 2007 714 725 10.1002/mnfr.200700024
29. R. González-Barrio, P. Truchado, and H. Ito UV and MS identification of urolithins and nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals J. Agric. Food Chem. 59 2011 1152 1162 10.1021/jf103894m
30. J.C. Espín, M. Larrosa, M.T. García-Conesa, and F. Tomás-Barberán Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far Evidence Based Complement Altern. Med. 2013 270418
31. J.C. Espín, M. Larrosa, M.T. García-Conesa, and F. Tomás-Barberán Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far Evidence Based Complement Altern. Med. 2013 2013 270418 10.1155/2013/270418
32. B. Cerdá, F.A. Tomás-Barberán, and J.C. Espín Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability J. Agric. Food Chem. 53 2005 227 235 10.1021/jf049144d
33. A. González-Sarrías, V. Miguel, and G. Merino The gut microbiota ellagic acid-derived metabolite urolithin a and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP) J. Agric. Food Chem. 61 2013 4352 4359 10.1021/jf4007505
34. A. González-Sarrías, J.A. Giménez-Bastida, and Núñez-Sánchez MÁ Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells Eur. J. Nutr. 53 2014 853 864 10.1007/s00394-013-0589-4
35. R. González-Barrio, C.A. Edwards, and A. Crozier Colonic catabolism of ellagitannins, ellagic acid, and raspberry anthocyanins: in vivo and in vitro studies Drug Metab. Dispos. 39 2011 1680 1688 10.1124/dmd.111.039651
36. J.M. Landete Ellagitannins, ellagic acid and their derived metabolites: a review about source, metabolism, functions and health Food Res. Int. 44 2011 1150 1160 10.1016/j.foodres.2011.04.027
37. N.P. Seeram, W.J. Aronson, and Y. Zhang Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland J. Agric. Food Chem. 55 2007 7732 7737 10.1021/jf071303g
38. R. González-Barrio, G. Borges, W. Mullen, and A. Crozier Bioavailability of anthocyanins and ellagitannins following consumption of raspberries by healthy humans and subjects with an ileostomy J. Agric. Food Chem. 58 2010 3933 3939 10.1021/jf100315d
39. M. Zahin, I. Ahmad, R.C. Gupta, and F. Aqil Punicalagin and ellagic acid demonstrate antimutagenic activity and inhibition of benzo[a]pyrene induced DNA adducts Biomed Res Int 2014 10.1155/2014/467465 467465
40. M.U. Rehman, M. Tahir, and F. Ali Cyclophosphamide-induced nephrotoxicity, genotoxicity, and damage in kidney genomic DNA of Swiss albino mice: the protective effect of ellagic acid Mol. Cell. Biochem. 365 2012 119 127 10.1007/s11010-012-1250-x
41. S.K. Abraham Anti-genotoxic effects in mice after the interaction between coffee and dietary constituents Food Chem. Toxicol. 34 1996 15 20 10.1016/0278-6915(95)00085-2
42. K.L. Khanduja, P.K. Avti, and S. Kumar Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism Biochim. Biophys. Acta 1760 2006 283 289
43. G. Türk, A.O. Ceribaşi, and F. Sakin Antiperoxidative and anti-apoptotic effects of lycopene and ellagic acid on cyclophosphamide-induced testicular lipid peroxidation and apoptosis Reprod. Fertil. Dev. 22 2010 587 596 10.1071/RD09078
44. H.-C. Ou, W.-J. Lee, and S.-D. Lee Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway Toxicol. Appl. Pharmacol. 248 2010 134 143 10.1016/j.taap.2010.07.025
45. T. Li, G. Chen, and C. Su Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells Anticancer Res. 25 2005 971 980
46. A.S. Abuelsaad, I. Mohamed, G. Allam, and A.A. Al-solumani Antimicrobial and immunomodulating activities of hesperidin and ellagic acid against diarrheic Aeromonas hydrophila in a murine model Life Sci. 93 2013 714 722 10.1016/j.lfs.2013.09.019
47. S.W. Park, M.J. Kwon, and J.Y. Yoo Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses BMC Complement Altern. Med. 14 2014 171 10.1186/1472-6882-14-171
48. P.N. Soh, B. Witkowski, and D. Olagnier In vitro and in vivo properties of ellagic acid in malaria treatment Antimicrob. Agents Chemother. 53 2009 1100 1106 10.1128/AAC.01175-08
49. Y.H. Choi, and G.H. Yan Ellagic Acid attenuates immunoglobulin E-mediated allergic response in mast cells Biol. Pharm. Bull. 32 2009 1118 1121
50. A. Promsong, C. Wo, S. Satthakarn, and W. Nittayananta Ellagic acid modulates the expression of oral innate immune mediators: potential role in mucosal protection J. Oral Pathol. Med. 2014 10.1111/jop.12223
51. N. El-Shitany, E. El-Bastawissy, and K. El-desoky Ellagic acid protects against carrageenan-induced acute inflammation through inhibition of nuclear factor kappa B, inducible cyclooxygenase and proinflammatory cytokines and enhancement of interleukin-10 via an antioxidant Int. Immunopharmacol. 19 2014 290 299 10.1016/j.intimp.2014.02.004
52. M.-Y. Kuo, H.-C. Ou, and W.-J. Lee Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/ J. Agric. Food Chem. 59 2011 5100 5108 10.1021/jf1041867
53. S. Pinto Mda, J.E. De Carvalho, and F.M. Lajolo Evaluation of antiproliferative, anti-type 2 diabetes, and antihypertension potentials of ellagitannins from strawberries (Fragaria × ananassa Duch.) using in vitro models J. Med. Foods 13 2010 1027 1035 10.1089/jmf.2009.0257
54. D. Dhingra, and A. Jangra Antiepileptic activity of ellagic acid, a naturally occurring polyphenolic compound, in mice J. Funct. Foods 10 2014 364 369 10.1016/j.jff.2014.07.011
55. D. Dhingra, and R. Chhillar Antidepressant-like activity of ellagic acid in unstressed and acute immobilization-induced stressed mice Pharmacol. Rep. 64 2012 796 807
56. C. Girish, V. Raj, J. Arya, and S. Balakrishnan Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice Eur. J. Pharmacol. 710 2013 49 58 10.1016/j.ejphar.2013.04.003
57. H. Kwak, S. Jeon, and B. Sohng beta-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk Arch. Pharm. Res. 28 2005 1328 1332
58. Saba, S. Khan, and S. Parvez Ellagic acid attenuates bleomycin and cyclophosphamide-induced pulmonary toxicity in Wistar rats Food Chem. Toxicol. 58 2013 210 219 10.1016/j.fct.2013.03.046
59. A.M. El-Garhy, O.M. Abd El-raouf, and B.M. El-sayeh Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats J. Biochem. Mol. Toxicol. 28 2014 472 479 10.1002/jbt.21587
60. M.M. Kannan, and S.D. Quine Ellagic acid inhibits cardiac arrhythmias, hypertrophy and hyperlipidaemia during myocardial infarction in rats Metabolism 62 2013 52 61 10.1016/j.metabol.2012.06.003
61. J.H. Lee, J.H. Won, and J.M. Choi Protective effect of ellagic acid on concanavalin A-induced hepatitis via Toll-like receptor and mitogen-activated protein kinase/nuclear factor κB signaling pathways J. Agric. Food Chem. 2014 10.1021/jf503188c
62. M. Rosenblat, N. Volkova, S. Judeinstein, and M. Aviram Anti-atherogenic properties of date vs. pomegranate polyphenols: the benefits of the combination Food Funct. 2015 10.1039/C4FO00998C
63. D. Bialonska, S.G. Kasimsetty, S.I. Khan, and D. Ferreira Urolithins, intestinal microbial metabolites of Pomegranate ellagitannins, exhibit potent antioxidant activity in a cell-based assay J. Agric. Food Chem. 57 2009 10181 10186 10.1021/jf9025794
64. J.P. Piwowarski, S. Granica, and A.K. Kiss Influence of gut microbiota-derived ellagitannins metabolites urolithins on pro-inflammatory activities of human neutrophils Planta Med. 80 2014 887 895 10.1055/s-0034-1368615
65. M. Larrosa, A. González-Sarrías, and M.J. Yáñez-Gascón Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism J. Nutr. Biochem. 21 2010 717 725 10.1016/j.jnutbio.2009.04.012
66. A. González-Sarrías, J.A. Giménez-Bastida, and M.T. García-Conesa Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice Mol. Nutr. Food Res. 54 2010 311 322 10.1002/mnfr.200900152
67. Z. Qiu, B. Zhou, and L. Jin In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells Food Chem. Toxicol. 59 2013 428 437 10.1016/j.fct.2013.06.025
68. M. Stolarczyk, J.P. Piwowarski, and S. Granica Extracts from Epilobium sp. Herbs, their components and gut microbiota metabolites of epilobium ellagitannins, urolithins, inhibit hormone-dependent prostate cancer cells-(LNCaP) proliferation and PSA secretion Phyther. Res. 27 2013 1842 1848 10.1002/ptr.4941
69. S.G. Kasimsetty, D. Blalonska, and M.K. Reddy Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins J. Agric. Food Chem. 58 2010 2180 2187 10.1021/jf903762h
70. M. Dell'Agli, G.V. Galli, and M. Bulgari Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria Malar. J. 9 2010 208 10.1186/1475-2875-9-208
71. E. Verzelloni, C. Pellacani, and D. Tagliazucchi Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites Mol. Nutr. Food Res. 55 2011 S35 S43 10.1002/mnfr.201000525
72. L.S. Adams, Y. Zhang, and N.P. Seeram Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro Cancer Prev. Res. 3 2010 108 113 10.1158/1940-6207.CAPR-08-0225
73. Y. Ding, B. Zhang, and K. Zhou Dietary ellagic acid improves oxidant-induced endothelial dysfunction and atherosclerosis: role of Nrf2 activation Int. J. Cardiol. 175 2014 508 514 10.1016/j.ijcard.2014.06.045
74. Y.-C. Hseu, C.-W. Chou, and K.J. Senthil Kumar Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes Food Chem. Toxicol. 50 2012 1245 1255 10.1016/j.fct.2012.02.020
75. D. Cornélio Favarin, M. Martins Teixeira, and E. Lemos de Andrade Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice Mediators Inflamm. 2013 2013 164202 10.1155/2013/164202
76. U.P. Rani, R. Kesavan, and R. Ganugula Ellagic acid inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and prevents atheroma formation in streptozotocin-induced diabetic rats J. Nutr. Biochem. 24 2013 1830 1839 10.1016/j.jnutbio.2013.04.004
77. L. Labrecque, S. Lamy, and A. Chapus Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound Carcinogenesis 26 2005 821 826 10.1093/carcin/bgi024
78. Y.M. Yu, Z.H. Wang, C.H. Liu, and C.S. Chen Ellagic acid inhibits IL-1beta-induced cell adhesion molecule expression in human umbilical vein endothelial cells Br. J. Nutr. 97 2007 692 698
79. Y.-C. Chung, L.-C. Lu, and M.-H. Tsai The inhibitory effect of ellagic acid on cell growth of ovarian carcinoma cells Evidence Based Complement Altern. Med. 2013 2013 306705 10.1155/2013/306705
80. S. Umesalma, and G. Sudhandiran Ellagic acid prevents rat colon carcinogenesis induced by 1,2 dimethyl hydrazine through inhibition of AKT-phosphoinositide-3 kinase pathway Eur. J. Pharmacol. 660 2011 249 258 10.1016/j.ejphar.2011.03.036
81. A. González-Sarrías, J.-C. Espín, F.a. Tomás-Barberán, and M.-T. García-Conesa Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins Mol. Nutr. Food Res. 53 2009 686 698 10.1002/mnfr.200800150
82. L. Vanella, C. Di Giacomo, and R. Acquaviva Apoptotic markers in a prostate cancer cell line: effect of ellagic acid Oncol. Rep. 30 2013 2804 2810 10.3892/or.2013.2757
83. S. Mishra, and M. Vinayak Ellagic acid checks lymphoma promotion via regulation of PKC signaling pathway Mol. Biol. Rep. 40 2013 1417 1428 10.1007/s11033-012-2185-8
84. J. Kowshik, H. Giri, and T.K. Kiran Kishore Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model Anticancer Agents Med. Chem. 2014 10.2174/1871520614666140723114217
85. L. Cesaratto, C. Vascotto, S. Calligaris, and G. Tell The importance of redox state in liver damage Ann. Hepatol. 3 2004 86 92
86. K. Rahman Studies on free radicals, antioxidants, and co-factors Clin. Interv. Aging 2 2007 219 236
87. P. Venkatesan, and M.N. Rao Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues J. Pharm. Pharmacol. 52 2000 1123 1128
88. R. Cozzi, R. Ricordy, and F. Bartolini Taurine and ellagic acid: two differently-acting natural antioxidants Environ. Mol. Mutagen. 26 1995 248 254
89. A. Nugroho, T.-J. Rhim, and M.-Y. Choi Simultaneous analysis and peroxynitrite-scavenging activity of galloylated flavonoid glycosides and ellagic acid in Euphorbia supina Arch. Pharm. Res. 37 2014 890 898 10.1007/s12272-013-0307-z
90. D. Ahn, D. Putt, and L. Kresty The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes Carcinogenesis 17 1996 821 828
91. G. Celik, A. Semiz, and S. Karakurt A comparative study for the evaluation of two doses of ellagic acid on hepatic drug metabolizing and antioxidant enzymes in the rat Biomed. Res. Int. 2013 2013 358945 10.1155/2013/358945
92. M. Buelna-Chontal, and C. Zazueta Redox activation of Nrf2 & NF-κB: a double end sword? Cell. Signal. 25 2013 2548 2557 10.1016/j.cellsig.2013.08.007
93. C. Gorrini, I.S. Harris, and T.W. Mak Modulation of oxidative stress as an anticancer strategy Nat. Rev. Drug Discov. 12 2013 931 947 10.1038/nrd4002
94. H. Motohashi, and M. Yamamoto Nrf2-Keap1 defines a physiologically important stress response mechanism Trends Mol. Med. 10 2004 549 557 10.1016/j.molmed.2004.09.003
95. D.D. Zhang Mechanistic studies of the Nrf2-Keap1 signaling pathway Drug Metab. Rev. 38 2006 769 789 10.1080/03602530600971974
96. Y.-J. Surh, and H.-K. Na NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals Genes Nutr. 2 2008 313 317 10.1007/s12263-007-0063-0
97. W.-L. Lee, J.-Y. Huang, and L.-F. Shyur Phytoagents for cancer management: regulation of nucleic acid oxidation, ROS, and related mechanisms Oxid. Med. Cell Longev. 2013 22
98. H. Kumar, I.-S. Kim, and S.V. More Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases Nat. Prod. Rep. 31 2014 109 139 10.1039/c3np70065h
99. D.H. Barch, L.M. Rundhaugen, and G.D. Stoner Structure-function relationships of the dietary anticarcinogen ellagic acid Carcinogenesis 17 1996 265 269 10.1093/carcin/17.2.265
100. A.G. Shepherd, M.M. Manson, H.W. Ball, and L.I. McLellan Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia Carcinogenesis 21 2000 1827 1834
101. Y.-S. Kim, T. Zerin, and H.-Y. Song Antioxidant action of ellagic acid ameliorates paraquat-induced A549 cytotoxicity Biol. Pharm. Bull. 36 2013 609 615
102. D.H. Barch, and L.M. Rundhaugen Ellagic acid induces NAD(P)H:quinone reductase through activation of the antioxidant responsive element of the rat NAD(P)H:quinone reductase gene Carcinogenesis 15 1994 2065 2068
103. L. Gu, W.-S. Deng, and Y. Liu Ellagic acid protects lipopolysaccharide/d-galactosamine-induced acute hepatic injury in mice Int. Immunopharmacol. 22 2014 341 345 10.1016/j.intimp.2014.07.005
104. V. Vijaya Padma, P. Kalai Selvi, and S. Sravani Protective effect of ellagic acid against TCDD-induced renal oxidative stress: modulation of CYP1A1 activity and antioxidant defense mechanisms Mol. Biol. Rep. 41 2014 4223 4232 10.1007/s11033-014-3292-5
105. K. Kavitha, P. Thiyagarajan, and J. Rathna Nandhini Chemopreventive effects of diverse dietary phytochemicals against DMBA-induced hamster buccal pouch carcinogenesis via the induction of Nrf2-mediated cytoprotective antioxidant, detoxification, and DNA repair enzymes Biochimie 95 2013 1629 1639 10.1016/j.biochi.2013.05.004
106. V.J. Navarro, and J.R. Senior Drug-related hepatotoxicity N. Engl. J. Med. 354 2006 731 739 10.1056/NEJMra052270
107. ATSDR Toxicological profile for carbon tetrachloride 2005 U.S. Department of Health and Human services. Agency for Toxic Substances and Disease Registry
108. S.M. Attia Deleterious effects of reactive metabolites Oxid. Med. Cell Longev. 3 2010 238 253 10.4161/oxim.3.4.13246
109. I. Rusyn, and R. Bataller Alcohol and toxicity J. Hepatol. 59 2013 387 388 10.1016/j.jhep.2013.01.035
110. D.L. Clemens Alcoholic pancreatitis: lessons from the liver World J. Gastroenterol. 16 2010 1314 1320 10.3748/wjg.v16.i11.1314
111. P. Mandrekar, and G. Szabo Signalling pathways in alcohol-induced liver inflammation J. Hepatol. 50 2009 1258 1266 10.1016/j.jhep.2009.03.007
112. I.H. McKillop, and L.W. Schrum Alcohol and liver cancer Alcohol 35 2005 195 203 10.1016/j.alcohol.2005.04.004
113. A. Srivastava, and T. Shivanandappa Hepatoprotective effect of the aqueous extract of the roots of Decalepis hamiltonii against ethanol-induced oxidative stress in rats Hepatol. Res. 35 2006 267 275 10.1016/j.hepres.2006.04.011
114. N. Devipriya, A.R. Sudheer, and V.P. Menon Dose-response effect of ellagic acid on circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats Fundam. Clin. Pharmacol. 21 2007 621 630 10.1111/j.1472-8206.2007.00551.x
115. N. Devipriya, A.R. Sudheer, P. Vishwanathan, and V.P. Menon Modulatory potential of ellagic acid, a natural plant polyphenol on altered lipid profile and lipid peroxidation status during alcohol-induced toxicity: a pathohistological study J. Biochem. Mol. Toxicol. 22 2008 101 112 10.1002/jbt.20226
116. D.H. Barch, L.M. Rundhaugen, and P.E. Thomas Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA Biochem. Biophys. Res. Commun. 201 1994 1477 1482
117. H. Szaefer, J. Jodynis-Liebert, and M. Cichocki Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine Toxicology 186 2003 67 77 10.1016/S0300-483X(02)00615-7
118. A. González-Sarrías, M. Azorín-Ortuño, and M.J. Yáñez-Gascón Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1 J. Agric. Food Chem. 57 2009 5623 5632 10.1021/jf900725e
119. S.V. Siegmund, and D.A. Brenner Molecular pathogenesis of alcohol-induced hepatic fibrosis Alcohol. Clin. Exp. Res. 29 2005 102S 109S 10.1097/01.alc.0000189275.97419.58
120. L. Ciuclan, S. Ehnert, and I. Ilkavets TGF-beta enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase I J. Hepatol. 52 2010 407 416 10.1016/j.jhep.2009.12.003
121. G. Malaguarnera, E. Cataudella, and M. Giordano Toxic hepatitis in occupational exposure to solvents World J. Gastroenterol. 18 2012 2756 2766 10.3748/wjg.v18.i22.2756
122. K. Toriumi, Y. Horikoshi, and R. Yoshiyuki Osamura Carbon tetrachloride-induced hepatic injury through formation of oxidized diacylglycerol and activation of the PKC/NF-κB pathway Lab Investig. 93 2013 218 229 10.1038/labinvest.2012.145
123. C.V. Andritoiu, L. Ochiuz, V. Andritoiu, and M. Popa Effect of apitherapy formulations against carbon tetrachloride-induced toxicity in Wistar rats after three weeks of treatment Molecules 19 2014 13374 13391 10.3390/molecules190913374
124. P.P. Simeonova, G.M. Gallucci, and T. Hulderman The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride Toxicol. Appl. Pharmacol. 177 2001 112 120
125. S. Chen, L. Zou, L. Li, and T. Wu The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2 PLoS ONE 8 2013 e53662 10.1371/journal.pone.0053662
126. A.A. Rahmat, F.A. Dar, and I.M. Choudhary Protection of CCl4-induced liver and kidney damage by phenolic compounds in leaf extracts of Cnestis ferruginea (de Candolle) Pharmacognosy Res. 6 2014 19 28 10.4103/0974-8490.122913
127. C. Girish, and S.C. Pradhan Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice J. Pharmacol. Pharmacother. 3 2012 149 155 10.4103/0976-500X.95515
128. H.J. Ko, J.H. Chen, and L.T. Ng Hepatoprotection of Gentiana scabra extract and polyphenols in liver of carbon tetrachloride-intoxicated mice J. Environ. Pathol. Toxicol. Oncol. 30 2011 179 187
129. K. Singh, A.K. Khanna, and R. Chander Hepatoprotective activity of ellagic acid against carbon tetrachloride induced hepatotoxicity in rats Indian J. Exp. Biol. 37 1999 1025 1026
130. M. Suzuki, N. Kuymazawa, and S. Ohta Protective effects of antioxidants on experimental liver injuries J. Pharm. Soc. Jpn. 110 1990 697 701
131. A. Nitha, S. Prabha, P. Ansil, and M. Latha Methanolic extract of Woodfordia fruticosa Kurz flowers ameliorates carbon tetrachloride-induced chronic hepatic fibrosis in rats Toxicol. Ind. Health 2014 10.1177/0748233714552120
132. R.Y. Tsang, T. Al-Fayea, and H.-J. Au Cisplatin overdose: toxicities and management Drug Saf. 32 2009 1109 1122 10.2165/11316640-000000000-00000
133. S. Dasari, and P. Bernard Tchounwou Cisplatin in cancer therapy: molecular mechanisms of action Eur. J. Pharmacol. 740 2014 364 378 10.1016/j.ejphar.2014.07.025
134. A.Y. Nasr Protective effect of aged garlic extract against the oxidative stress induced by cisplatin on blood cells parameters and hepatic antioxidant enzymes in rats Toxicol. Rep. 1 2014 682 691 10.1016/j.toxrep.2014.09.003
135. A. Koc, M. Duru, and H. Ciralik Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats Mol. Cell. Biochem. 278 2005 79 84 10.1007/s11010-005-6630-z
136. T. Gómez-Sierra, E. Molina-Jijón, and E. Tapia S-allylcysteine prevents cisplatin-induced nephrotoxicity and oxidative stress J. Pharm. Pharmacol. 66 2014 1271 1281 10.1111/jphp.12263
137. A. Yüce, A. Ateşşahin, A.O. Ceribaşi, and M. Aksakal Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats Basic Clin. Pharmacol. Toxicol. 101 2007 345 349 10.1111/j.1742-7843.2007.00129.x
138. M. Waseem, and S. Parvez Mitochondrial dysfunction mediated cisplatin induced toxicity: modulatory role of curcumin Food Chem. Toxicol. 53 2013 334 342 10.1016/j.fct.2012.11.055
139. G. Kursunluoglu, H.A. Kayali, and D. Taskiran The effect of cisplatin toxicity and capsaicin on electron transport chain in liver and kidney of sprague dawley rats Cell Biochem. Biophys. 69 2014 707 716 10.1007/s12013-014-9857-z
140. K.K. Kumari, and O.H. Setty Protective effect of Phyllanthus fraternus against mitochondrial dysfunction induced by co-administration of cisplatin and cyclophosphamide J. Bioenerg. Biomembr. 44 2012 179 188 10.1007/s10863-012-9423-6
141. A. Ateşşahín, A.O. Ceríbaşi, and A. Yuce Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats Basic Clin. Pharmacol. Toxicol. 100 2007 121 126
142. N. Al-Kharusi, H.A. Babiker, and S. Al-Salam Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study Eur. Rev. Med. Pharmacol. Sci. 17 2013 299 310
143. G. Türk, A.O. CeribaşI, E. Sahna, and A. Ateşşahin Lycopene and ellagic acid prevent testicular apoptosis induced by cisplatin Phytomedicine 18 2011 356 361 10.1016/j.phymed.2010.07.008
144. G. Türk, A. Ateşşahin, and M. Sönmez Improvement of cisplatin-induced injuries to sperm quality, the oxidant-antioxidant system, and the histologic structure of the rat testis by ellagic acid Fertil. Steril. 89 2008 1474 1481
145. M. Leist, and A. Wendel A novel mechanism of murine hepatocyte death inducible by concanavalin A J. Hepatol. 25 1996 948 959 10.1016/S0168-8278(96)80301-1
146. M. Al-Shamsi, A. Shahin, E.P.K. Mensah-Brown, and A.-K. Souid Derangements of liver tissue bioenergetics in concanavalin A-induced hepatitis BMC Gastroenterol. 13 2013 6 10.1186/1471-230X-13-6
147. H. Shirin, H. Aeed, and A. Alin Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers Dig. Dis. Sci. 55 2010 268 275 10.1007/s10620-009-0732-5
148. X. Xu, H. Wei, and Z. Dong The differential effects of low dose and high dose concanavalin A on cytokine profile and their importance in liver injury Inflamm. Res. 55 2006 144 152 10.1007/s00011-006-0064-2
149. N. Tsuruoka, K. Abe, and K. Wake Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice Inflamm. Res. 58 2009 593 599 10.1007/s00011-009-0024-8
150. G. Shi, Z. Zhang, and R. Zhang Protective effect of andrographolide against concanavalin A-induced liver injury Naunyn. Schmiedebergs Arch. Pharmacol. 385 2012 69 79 10.1007/s00210-011-0685-z
151. H. Nakashima, M. Kinoshita, and M. Nakashima Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice Hepatology 48 2008 1979 1988 10.1002/hep.22561
152. J.M. Hwang, J.S. Cho, T.H. Kim, and Y.I. Lee Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species Biomed. Pharmacother. 64 2010 264 270 10.1016/j.biopha.2009.06.013
153. J. Lee Use of antioxidants to prevent cyclosporine a toxicity Toxicol. Res. 26 2010 163 170 10.5487/TR.;1; 2010.26.3.163
154. R. Rezzani, B. Buffoli, and L. Rodella Protective role of melatonin in cyclosporine A-induced oxidative stress in rat liver Int. Immunopharmacol. 5 2005 1397 1405 10.1016/j.intimp.2005.03.021
155. Z. Mostafavi-Pour, F. Khademi, and F. Zal In vitro analysis of CsA-induced hepatotoxicity in HepG2 cell line: oxidative stress and α2 and β1 integrin subunits expression Hepat. Mon. 13 2013 e11447 10.5812/hepatmon.11447
156. H.H. Hagar The protective effect of taurine against cyclosporine A-induced oxidative stress and hepatotoxicity in rats Toxicol. Lett. 151 2004 335 343 10.1016/j.toxlet.2004.03.002
157. R. Rezzani Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies Histol. Histopathol. 21 2006 301 316
158. Z. Zhong, X. Li, and S. Yamashina Cyclosporin A causes a hypermetabolic state and hypoxia in the liver: prevention by dietary glycine J. Pharmacol. Exp. Ther. 299 2001 858 865
159. L. Pari, and R. Sivasankari Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats Fundam. Clin. Pharmacol. 22 2008 395 401 10.1111/j.1472-8206.2008.00609.x
160. A. Yüce, A. Ateşşahin, and A.O. Ceribaşi Amelioration of cyclosporine A-induced renal, hepatic and cardiac damages by ellagic acid in rats Basic Clin. Pharmacol. Toxicol. 103 2008 186 191 10.1111/j.1742-7843.2008.00284.x
161. K. Sonaje, J.L. Italia, and G. Sharma Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats Pharm. Res. 24 2007 899 908 10.1007/s11095-006-9207-y
162. G. Sharma, J.L. Italia, and K. Sonaje Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats J. Control. Release 118 2007 27 37 10.1016/j.jconrel.2006.11.026
163. Y.-H. Wu, S.-Q. Hu, and J. Liu Nature and mechanisms of hepatocyte apoptosis induced by d-galactosamine/lipopolysaccharide challenge in mice Int. J. Mol. Med. 33 2014 1498 1506 10.3892/ijmm.2014.1730
164. B. Hocher, S. Heiden, and K. von Websky Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with d-galactosamine-induced liver failure Eur. J. Med. Res. 16 2011 275 279
165. J. Das, J. Ghosh, A. Roy, and P.C. Sil Mangiferin exerts hepatoprotective activity against d-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways Toxicol. Appl. Pharmacol. 260 2012 35 47 10.1016/j.taap.2012.01.015
166. H. Wang, D.-X. Xu, and J.-W. Lv Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in d-galactosamine-sensitized mice Toxicology 237 2007 49 57 10.1016/j.tox.2007.04.021
167. S.C. Gupta, A.K. Tyagi, and P. Deshmukh-Taskar Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols Arch. Biochem. Biophys. 559 2014 91 99 10.1016/j.abb.2014.06.006
168. J.A. Giménez-Bastida, M. Larrosa, and A. González-Sarrías Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts J. Agric. Food Chem. 60 2012 8866 8876 10.1021/jf300290f
169. J.P. Piwowarski, S. Granica, and M. Zwierzyńska Role of human gut microbiota metabolism in the anti-inflammatory effect of traditionally used ellagitannin-rich plant materials J. Ethnopharmacol. 155 2014 801 809 10.1016/j.jep.2014.06.032
170. A. González-Sarrías, M. Larrosa, and F.A. Tomás-Barberán NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts Br. J. Nutr. 104 2010 503 512 10.1017/S0007114510000826
171. F. Li, J. Lu, and J. Cheng Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy Nat. Med. 19 2013 418 420 10.1038/nm.3104
172. S. Mita, H. Suzuki, and H. Akita Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs Drug Metab. Dispos. 34 2006 1575 1581 10.1124/dmd.105.008748
173. J.J. Saukkonen, D.L. Cohn, and R.M. Jasmer An official ATS statement: hepatotoxicity of antituberculosis therapy Am. J. Respir. Crit. Care Med. 174 2006 935 952 10.1164/rccm.200510-1666ST
174. S.K. Jatav, A. Kulshrestha, and A. Zacharia Spirulina maxima protects liver from isoniazid and rifampicin drug toxicity J. Evid. Based Complementary Altern. Med. 19 2014 189 194 10.1177/2156587214530720
175. S.A. Tasduq, K. Peerzada, and S. Koul Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin Hepatol. Res. 31 2005 132 135 10.1016/j.hepres.2005.01.005
176. S.S. Ambrose, P. Solairaj, and A. Subramoniam Effectiveness of ellagic acid on isoniazid-rifampicin induced liver damage in rats J. Pharmacol. Pharmacother. 4 2013 60 62 10.4103/0976-500X.107684
177. H.H. Lo, S.E. Hsieh, K.J. Tsai, and J.G. Chung The effects of ellagic acid on arylamine N-acetyltransferase activity in the bacterium Pseudomonas aeruginosa Drug Chem. Toxicol. 22 1999 555 562
178. S. Lin, C. Hung, and Y. Tyan Ellagic acid inhibits arylamine N-acetyltransferase activity and DNA adduct formation in human bladder tumor cell lines (T24 and TSGH 8301) Urol. Res. 29 2001 371 376 10.1007/s002400100213
179. J.C. Chung Inhibitory actions of ellagic acid on growth and arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients Microbios 93 1998 115 127
180. ATSDR Toxicological profile for mercury 1999 Agency for Toxic Substances and Disease Registry
181. C. Bridges, J. Battle, and R. Zalups Transport of thiol-conjugates of inorganic mercury in human retinal pigment epithelial cells Toxicol. Appl. Pharmacol. 221 2007 251 260 10.1016/j.taap.2007.03.004
182. N.H. Stacey, and H. Kappus Cellular toxicity and lipid peroxidation in response to mercury Toxicol. Appl. Pharmacol. 63 1982 29 35
183. Y.L. Huang, S.L. Cheng, and T.H. Lin Lipid peroxidation in rats administrated with mercuric chloride Biol. Trace Elem. Res. 52 1996 193 206 10.1007/BF02789461
184. T.H. Lin, Y.L. Huang, and S.F. Huang Lipid peroxidation in liver of rats administrated with methyl mercuric chloride Biol. Trace Elem. Res. 54 1996 33 41 10.1007/BF02785318
185. L.C. Benov, I.C. Benchev, and O.H. Monovich Thiol antidotes effect on lipid peroxidation in mercury-poisoned rats Chem. Biol. Interact. 76 1990 321 332
186. L. Chang, and S. Yamaguchi Ultrastructural changes in the liver after long-term diet of mercury-contaminated tuna Environ. Res. 7 1974 133 148
187. P.A. Desnoyers, and L.W. Chang Ultrastructural changes in rat hepatocytes following acute methyl mercury intoxication Environ. Res. 9 1975 224 239
188. S. Kanluen, and C.A. Gottlieb A clinical pathologic study of four adult cases of acute mercury inhalation toxicity Arch. Pathol. Lab. Med. 115 1991 56 60
189. H. Ashour, M. Abdel-Rahman, and A. Khodair The mechanism of methyl mercury toxicity in isolated rat hepatocytes Toxicol. Lett. 69 1993 87 96
190. D. Joshi, D. Mittal, and S. Shrivastav Combined effect of N-acetyl cysteine, zinc, and selenium against chronic dimethylmercury-induced oxidative stress: a biochemical and histopathological approach Arch. Environ. Contam. Toxicol. 61 2011 558 567 10.1007/s00244-011-9656-0
191. D. Joshi, D. Mittal, S. Shukla, and A. Srivastav Therapeutic potential of N-acetyl cysteine with antioxidants (Zn and Se) supplementation against dimethylmercury toxicity in male albino rats Exp. Toxicol. Pathol. 64 2012 103 108 10.1016/j.etp.2010.07.001
192. Y. Cao, X. Chen, and Z. Zhou Study on different doses of mercury-containing preparations on acute toxicity in rabbits China J. Chin. Mater. Med. 37 2012 723 727
193. L.W. Chang, R.A. Ware, and P.A. Desnoyers A histochemical study on some enzyme changes in the kidney, liver and brain after chronic mercury intoxication in the rat Food Cosmet. Toxicol. 11 1973 283 286
194. E. Bharathi, G. Jagadeesan, and M. Vijayakumar Hepato-ameliorative effect of hesperidin and ellagic acid on mercuric chloride intoxicated rats Biomed. Aging Pathol. 4 2014 17 21 10.1016/j.biomag.2013.10.002
195. G. Jagadeesan, and E. Bharathi In vivo restoration of hepatic and nephro protective potential of hesperidin and ellagic acid against mercuric chloride intoxicated rats Biomed. Aging Pathol. 4 2014 219 222 10.1016/j.biomag.2014.01.008
196. M. Karamać Chelation of Cu(II), Zn(II), and Fe(II) by tannin constituents of selected edible nuts Int. J. Mol. Sci. 10 2009 5485 5497 10.3390/ijms10125485
197. I.F. Almeida, P. Valentão, and P.B. Andrade Oak leaf extract as topical antioxidant: free radical scavenging and iron chelating activities and in vivo skin irritation potential Biofactors 33 2008 267 279
198. S.-T. Huang, R.-C. Yang, and H.-T. Wu Zinc-chelation contributes to the anti-angiogenic effect of ellagic acid on inhibiting MMP-2 activity, cell migration and tube formation PLoS ONE 6 2011 e18986 10.1371/journal.pone.0018986
199. S. Ahmed, A. Rahman, and M. Saleem Ellagic acid ameliorates nickel induced biochemical alterations: diminution of oxidative stress Hum. Exp. Toxicol. 18 1999 691 698
200. F. Ashoori, S. Suzuki, and Z. Jh Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid Plast. Reconstr. Surg. 94 1994 1027 1037
201. E. Belyaeva, S.M. Korotkov, and N.-E. Saris In vitro modulation of heavy metal-induced rat liver mitochondria dysfunction: a comparison of copper and mercury with cadmium J. Trace Elem. Med. Biol. 25S 2011 S63 S73 10.1016/j.jtemb.2010.10.007
202. P.A. Desnoyers, and L.W. Chang Ultrastructural changes in the liver after chronic exposure to methylmercury Environ. Res. 10 1975 59 75
203. Y. Gong, G. Wang, and J. Yan Hepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity BMC Gastroenterol. 14 2014 44 10.1186/1471-230X-14-44
204. W. Bernal, T.J.S. Cross, and G. Auzinger Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience J. Hepatol. 50 2009 306 313 10.1016/j.jhep.2008.09.012
205. W.S. Waring Novel acetylcysteine regimens for treatment of paracetamol overdose Ther. Adv. Drug Saf. 3 2012 305 315 10.1177/2042098612464265
206. G.R. Bond, M. Ho, and R.W. Woodward Trends in hepatic injury associated with unintentional overdose of paracetamol (Acetaminophen) in products with and without opioid: an analysis using the National Poison Data System of the American Association of Poison Control Centers, 2000-7 Drug Saf. 35 2012 149 157 10.2165/11595890-000000000-00000
207. H. Jaeschke, C.D. Williams, A. Ramachandran, and M.L. Bajt Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity Liver Int. 32 2013 8 20 10.1111/j.1478-3231.2011.02501.x
208. M.R. McGill, and H. Jaeschke Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis Pharm. Res. 30 2013 2174 2187 10.1007/s11095-013-1007-6
209. E. Kheradpezhouh, L. Ma, and A. Morphett TRPM2 channels mediate acetaminophen-induced liver damage Proc. Natl. Acad. Sci. U. S. A. 111 2014 3176 3181 10.1073/pnas.1322657111
210. A. Ramachandran, M.R. McGill, and Y. Xie The receptor interacting protein kinase 3 is a critical early mediator of acetaminophen-induced hepatocyte necrosis in mice Hepatology 58 2013 2099 2108 10.1002/hep.26547
211. C. Girish, B.C. Koner, and S. Jayanthi Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice Fundam. Clin. Pharmacol. 23 2009 735 745 10.1111/j.1472-8206.2009.00722.x
212. J.K. Hongslo, C.V. Smith, and G. Brunborg Genotoxicity of paracetamol in mice and rats Mutagenesis 9 1994 93 100
213. K. Oshida, E. Iwanaga, K. Miyamoto-Kuramitsu, and Y. Miyamoto An in vivo comet assay of multiple organs (liver, kidney and bone marrow) in mice treated with methyl methanesulfonate and acetaminophen accompanied by hematology and/or blood chemistry J. Toxicol. Sci. 33 2008 515 524
214. R.H. Hussein, and F.K. Khalifa The protective role of ellagitannins flavonoids pretreatment against N-nitrosodiethylamine induced-hepatocellular carcinoma Saudi J. Biol. Sci. 21 2014 589 596 10.1016/j.sjbs.2014.03.004
215. NCHS NHANES III. Hepatic steatosis ultrasound images assessment procedures manual 2010 National Center for Health Statistics http://www.cdc.gov/nchs/data/nhanes/nhanes3/Hepatic-Steatosis-Ultrasound-Procedures-Manual.pdf (accessed 09.01.15)
216. G. Bedogni, V. Nobili, and C. Tiribelli Epidemiology of fatty liver: an update World J. Gastroenterol. 20 2014 9050 9054 10.3748/wjg.v20.i27.9050
217. E.M. Brunt Pathology of fatty liver disease Mod. Pathol. 20 Suppl. 1 2007 S40 S48 10.1038/modpathol.3800680
218. C.P. Day, and O.F. James Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463 1466
219. N. Anderson, and J. Borlak Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis Pharmacol. Rev. 60 2008 311 357 10.1124/pr.108.00001
220. C.P. Day, and O.F. James Steatohepatitis: a tale of two "hits"? Gastroenterology 114 1998 842 845
221. Y. Yoshimura, S. Nishii, and N. Zaima Ellagic acid improves hepatic steatosis and serum lipid composition through reduction of serum resistin levels and transcriptional activation of hepatic ppara in obese, diabetic KK-A(y) mice Biochem. Biophys. Res. Commun. 434 2013 486 491 10.1016/j.bbrc.2013.03.100
222. P. Singla, A. Bardoloi, and A.A. Parkash Metabolic effects of obesity: a review World J. Diabetes 1 2010 76 88 10.4239/wjd.v1.i3.76
223. L.F. Van Gaal, A. Zhang, M.M. Steijaert, and I.H. De Leeuw Human obesity: from lipid abnormalities to lipid oxidation Int. J. Obes. Relat. Metab. Disord. 19 Suppl. 3 1995 S21 S26
224. H.A. Khan, S.H. Sobki, and S.A. Khan Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia Clin. Exp. Med. 7 2007 24 29 10.1007/s10238-007-0121-3
225. R.M. Krauss Lipids and lipoproteins in patients with type 2 diabetes Diabetes Care 27 2004 1496 1504 10.2337/diacare.27.6.1496
226. S. Eaton, K. Bartlett, and M. Pourfarzam Mammalian mitochondrial beta-oxidation Biochem. J. 320 1996 345 357
227. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic and clinical implications Hepatology 51 2010 679 689 10.1002/hep.23280
228. Y.-X. Wang PPARs: diverse regulators in energy metabolism and metabolic diseases Cell Res. 20 2010 124 137 10.1038/cr.2010.13
229. F.A. Monsalve, R.D. Pyarasani, F. Delgado-Lopez, and R. Moore-Carrasco Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases Mediators Inflamm. 2013 2013 549627 10.1155/2013/549627
230. B. Grygiel-Górniak Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review Nutr. J. 13 2014 17 10.1186/1475-2891-13-17
231. R. Liu, J. Li, and Y. Cheng Effects of ellagic acid-rich extract of pomegranates peel on regulation of cholesterol metabolism and itsmolecular mechanism in hamsters Food Funct. 2015 10.1039/C4FO00759J
232. M. Okla, I. Kang, and D. Mi Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms J. Nutr. Biochem. 26 2015 82 90
233. H. Xu, G.T. Barnes, and Q. Yang Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J. Clin. Invest. 112 2003 1821 1830
234. U.J. Jung, and M.-S. Choi Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease Int. J. Mol. Sci. 15 2014 6184 6223
235. A. Aguilar-Valles, W. Inoue, C. Rummel, and G.N. Luheshi Obesity, adipokines and neuroinflammation Neuropharmacology 2015 1 11 10.1016/j.neuropharm.2014.12.023
236. Y. Ikeda, H. Tsuchiya, and S. Hama Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells FEBS J. 280 2013 5884895 10.1111/febs.12514
237. V. Leal, O. de, and D. Mafra Adipokines in obesity Clin. Chim. Acta 419 2013 87 94 10.1016/j.cca.2013.02.003
238. Y. Makino-Wakagi, Y. Yoshimura, and Y. Uzawa Ellagic acid in pomegranate suppresses resistin secretion by a novel regulatory mechanism involving the degradation of intracellular resistin protein in adipocytes Biochem. Biophys. Res. Commun. 417 2012 880 885 10.1016/j.bbrc.2011.12.067
239. G. Zollner, and M. Trauner Molecular mechanisms of cholestasis Wien. Med. Wochenschr. 156 2006 380 385 10.1007/s10354-006-0312-7
240. K.D. Nguyen, V. Sundaram, and W.S. Ayoub Atypical causes of cholestasis World J. Gastroenterol. 20 2014 9418 9426 10.3748/wjg.v20.i28.9418
241. G.M. Hirschfield, R.W. Chapman, and T.H. Karlsen The genetics of complex cholestatic disorders Gastroenterology 144 2013 1357 1374 10.1053/j.gastro.2013.03.053
242. E. Halilbasic, A. Baghdasaryan, and M. Trauner Nuclear receptors as drug targets in cholestatic liver diseases Clin. Liver Dis. 17 2013 161 189 10.1016/j.cld.2012.12.001
243. G.M. Hirschfield, E.J. Heathcote, and M.E. Gershwin Pathogenesis of cholestatic liver disease and therapeutic approaches Gastroenterology 139 2010 1481 1496 10.1053/j.gastro.2010.09.004
244. M. Gümüş, H. Yüksel, and O. Evliyaoʇlu Effects of ellagic acid on copper, zinc, and biochemical values in serum and liver of experimental cholestatic rats Biol. Trace Elem. Res. 143 2011 386 393 10.1007/s12011-010-8863-2
245. D. Rahelić, M. Kujundzić, and Z. Romić Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis Coll. Antropol. 30 2006 523 528
246. N.L. Ibrahim Study of serum copper and iron in children with chronic liver diseases Anat. Physiol. 4 2013 1 34 10.4172/2161-0940.1000130
247. M.A. Mohammed, Elmaksoud MDEAE, and N.A.E. Maksoud Serum levels of trace elements in Egyptian patients with chronic hepatitis C under interferon therapy J. Genet. Eng. Biotechnol. 10 2012 81 86 10.1016/j.jgeb.2012.03.001
248. K. Grüngreiff, and D. Reinhold Liver cirrhosis and "liver" diabetes mellitus are linked by zinc deficiency Med. Hypotheses 64 2005 316 317 10.1016/j.mehy.2004.04.030
249. J.R. Prohaska, and A.A. Gybina Intracellular copper transport in mammals J. Nutr. 134 2004 1003 1006
250. L.P. Thornburg A perspective on copper and liver disease in the dog J. Vet. Diagn. Investig. 12 2000 101 110 10.1177/104063870001200201
251. H. Kodama, C. Fujisawa, and W. Bhadhprasit Inherited coppertransport disorders: biochemical mechanisms, diagnosis, and treatment Curr. Drug Metab. 13 2012 237 250 10.2174/138920012799320455
252. H. Chuttani, P. Gupta, S. Gulati, and D. Gupta Acute copper sulfate poisoning Am. J. Med. 39 1965 849 854
253. C. Hébert, M. Elwell, and G. Travlos Subchronic toxicity of cupric sulfate administered in drinking water and feed to rats and mice Fundam. Appl. Toxicol. 21 1993 461 475
254. M. Giuliodori, C. Ramírez, and M. Ayala Acute copper intoxication after a Cu-Ca EDTA injection in rats Toxicology 124 1997 173 177
255. T.M. Bray, and W.J. Bettger The physiological role of zinc as an antioxidant Free Radic. Biol. Med. 8 1990 281 291
256. I. Stamoulis, G. Kouraklis, and S. Theocharis Zinc and the liver: an active interaction Dig. Dis. Sci. 52 2007 1595 1612 10.1007/s10620-006-9462-0
257. E. Mocchegiani, M. Muzzioli, and R. Giacconi Zinc, metallothioneins, immune responses, survival and ageing Biogerontology 1 2000 133 143
258. N. Stacey, and C. Klaassen Copper toxicity in isolated rat hepatocytes Toxicol. Appl. Pharmacol. 58 1981 211 220
259. R. Sokol, D. Twedt, and J.J. McKim Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis Gastroenterology 107 1994 1788 1798
260. M. Jozefczak, T. Remans, J. Vangronsveld, and A. Cuypers Glutathione is a key player in metal-induced oxidative stress defenses Int. J. Mol. Sci. 13 2012 3145 3175 10.3390/ijms13033145
261. T. Nakatani, L. Spolter, and K. Kobayashi Redox state in liver mitochondria in acute copper sulfate poisoning Life Sci. 54 1994 967 974
262. J. Pourahmad, and P. O'Brien A comparison of hepatocyte cytotoxic mechanisms for Cu2+ and Cd2+ Toxicology 143 2000 263 273
263. D.C. Rockey, and S.L. Friedman Hepatic fibrosis and cirrhosis T. Boyer, M. Manns, Zakim Boyer's Hepatol. A Textbook of Liver Disease 2012 Elsevier Saunders Philadelphia, PA 64 85
264. D. Kershenobich, and A. Bonder Liver fibrosis and inflammation. A review Ann. Hepatol. 2 2003 159 163
265. X. Liu, H. Hu, and J.Q. Yin Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis Liver Int. 26 2006 8 22 10.1111/j.1478-3231.2005.01192.x
266. A.M. Gressner, and R. Weiskirchen Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-b as major players and therapeutic targets J. Cell. Mol. Med. 10 2006 76 99 10.1111/j.1582-4934.2006.tb00292.x
267. S. Zhang, W.Y. Sun, J.J. Wu, and W. Wei TGF-β signaling pathway as a pharmacological target in liver diseases Pharmacol. Res. 85 2014 15 22 10.1016/j.phrs.2014.05.005
268. G.H. Buniatian Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture Cell Prolif. 36 2003 307 319
269. N. Devipriya, A.R. Sudheer, M. Srinivasan, and V.P. Menon Effect of ellagic acid, a plant polyphenol, on fibrotic markers (MMPs and TIMPs) during alcohol-induced hepatotoxicity Toxicol. Mech. Methods 17 2007 349 356 10.1080/15376510601077003
270. Z.-M. Hao, X.-B. Fan, and S. Li Vaccination with platelet-derived growth factor B kinoids inhibits CCl4 -induced hepatic fibrosis in mice J. Pharmacol. Exp. Ther. 342 2012 835 842
271. N. Kawada Evolution of hepatic fibrosis research Hepatol. Res. 41 2011 199 208 10.1111/j.1872-034X.2011.00776.x
272. N. Suzuki, A. Masamune, and K. Kikuta Ellagic acid inhibits pancreatic fibrosis in male wistar bonn/kobori rats Dig. Dis. Sci. 54 2009 802 810 10.1007/s10620-008-0423-7
273. A. Masamune, M. Satoh, and K. Kikuta Ellagic acid blocks activation of pancreatic stellate cells Biochem. Pharmacol. 70 2005 869 878
274. M. Erkan, N. Weis, and Z. Pan Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells Mol. Cancer 9 2010 88 10.1186/1476-4598-9-88
275. P. Bedossa, and V. Paradis Liver extracellular matrix in health and disease J. Pathol. 200 2003 504 515 10.1002/path.1397
276. V. Sanchez-Valle, N.C. Chavez-Tapia, M. Uribe, and N. Mendez-Sanchez Role of oxidative stress and molecular changes in liver fibrosis: a review Curr. Med. Chem. 19 2012 4850 4860 10.2174/092986712803341520
277. T. Severi, H. van Malenstein, C. Verslype, and J.F. van Pelt Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets Acta Pharmacol. Sin. 31 2010 1409 1420 10.1038/aps.2010.142
278. M. Maida, E. Orlando, C. Cammà, and G. Cabibbo Staging systems of hepatocellular carcinoma: a review of literature World J. Gastroenterol. 20 2014 4141 4150 10.3748/wjg.v20.i15.4141
279. S. Jelic, and G.C. Sotiropoulos Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann. Oncol. 21 2010 v59 v64 10.1093/annonc/mdq166
280. D.Y.-K. But, C.-L. Lai, and M.-F. Yuen Natural history of hepatitis-related hepatocellular carcinoma World J. Gastroenterol. 14 2008 1652 1656 10.3748/wjg.14.1652
281. P. Merle, and C. Trepo Molecular mechanisms underlying hepatocellular carcinoma Viruses 1 2009 852 872 10.3390/v1030852
282. J. Gao, L. Xie, and W.-S. Yang Risk factors of hepatocellular carcinoma - current status and perspectives Asian Pacific J. Cancer Prev. 13 2012 743 752
283. G. Baffy, E.M. Brunt, and S.H. Caldwell Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J. Hepatol. 56 2012 1384 1391 10.1016/j.jhep.2011.10.027
284. P. Czekaj Molecular and cellular mechanisms of chemically induced hepatocarcinogenesis Polish J. Environ. Stud. 13 2004 477 486
285. T. Karatzas, J. Maroulis, and D. Karavias Long-term survival of a patient with a large unresectable hepatocellular carcinoma: case report and review of the literature Open Surg. J. 4 2010 1 6 10.2174/1874300501004010001
286. J.D. Yang, and L.R. Roberts Hepatocellular carcinoma: a global view Nat. Rev. Gastroenterol. Hepatol. 7 2010 448 458 10.1038/nrgastro.2010.100
287. S.C. Lu Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 51 2010 734 736 10.1002/hep.23497
288. S. Singh, P.P. Singh, L.R. Roberts, and W. Sanchez Chemopreventive strategies in hepatocellular carcinoma Nat. Rev. Gastroenterol. Hepatol. 11 2014 45 54 10.1038/nrgastro.2013.143
289. P.S. Bisen, S.S. Bundela, and A. Sharma Ellagic acid - chemopreventive role in oral cancer J. Cancer Sci. Ther. 4 2012 23 30 10.4172/1948-5956.1000106
290. R. Vidya Priyadarsini, N. Kumar, and I. Khan Gene expression signature of DMBA-induced hamster buccal pouch carcinomas: modulation by chlorophyllin and ellagic acid PLoS ONE 7 2012 1 9 10.1371/journal.pone.0034628
291. J.G. De Boer, H. Yang, J. Holcroft, and K. Skov Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus Nutr. Cancer 50 2004 168 173 10.1207/s15327914nc5002-6
292. G.D. Stoner, and M.A. Morse Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer Cancer Lett. 114 1997 113 119 10.1016/S0304-3835(97)04639-9
293. M.V. Vadhanam, S. Ravoori, F. Aqil, and R.C. Gupta Chemoprevention of mammary carcinogenesis by sustained systemic delivery of ellagic acid Eur. J. Cancer Prev. 20 2011 484 491 10.1097/CEJ.0b013e3283498e00
294. R. Munagala, F. Aqil, M.V. Vadhanam, and R.C. Gupta MicroRNA "signature" during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention Cancer Lett. 10 2013 175 184 10.1016/j.canlet.2013.06.012
295. K.L. Khanduja, R.K. Gandhi, V. Pathania, and N. Syal Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice Food Chem. Toxicol. 37 1999 313 318 10.1016/S0278-6915(99)00021-6
296. T. Chewonarin, M. Tang, and P. Pitchakarn Ellagic acid, a component of pomegranate fruit juice, suppresses androgen-dependent prostate carcinogenesis via induction of apoptosis Prostate 75 2015 151 160 10.1002/pros.22900
297. E. Päivärinta, A.-M. Pajari, R. Törrönen, and M. Mutanen Ellagic acid and natural sources of ellagitannins as possible chemopreventive agents against intestinal tumorigenesis in the Min mouse Nutr. Cancer 54 2006 79 83 10.1207/s15327914nc5401-9
298. S. Umesalma, and G. Sudhandiran Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kB, iNOS, COX-2, TNF-a, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis Basic Clin. Pharmacol. Toxicol. 107 2010 650 655 10.1111/j.1742-7843.2010.00565.x
299. K.N. Kumar, S.B. Raja, N. Vidhya, and S.N. Devaraj Ellagic acid modulates antioxidant status, ornithine decarboxylase expression, and aberrant crypt foci progression in 1,2-dimethylhydrazine-instigated colon preneoplastic lesions in rats J. Agric. Food Chem. 60 2012 3665 3672 10.1021/jf204128z
300. T. Zhang, H. Chen, and L. Wang Ellagic acid exerts anti-proliferation effects via modulation of Tgf-B/Smad3 signaling in MCF-7 breast cancer cells Asian Pacific J. Cancer Prev. 15 2014 273 276
301. L. Vanella, C. Di Giacomo, and R. Acquaviva Effects of ellagic acid on angiogenic factors in prostate cancer cells Cancers (Basel) 5 2013 726 738 10.3390/cancers5020726
302. S. Umesalma, P. Nagendraprabhu, and G. Sudhandiran Ellagic acid inhibits proliferation and induced apoptosis via the Akt signaling pathway in HCT-15 colon adenocarcinoma cells Mol. Cell. Biochem. 399 2015 303 313 10.1007/s11010-014-2257-2
303. T. Kallio, J. Kallio, and M. Jaakkola Urolithins display both antioxidant and pro-oxidant activities depending on assay system and conditions J. Agric. Food Chem. 61 2013 10720 10729 10.1021/jf403208d
304. T. Tanaka, H. Iwata, and K. Niwa Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats Jpn. J. Cancer Res. 79 1988 1297 1303
305. M. Das, D.R. Bickers, and H. Mukhtar Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action Carcinogenesis 6 1985 1409 1413
306. S. Srigopalram, I.A. Jayraaj, and B. Kaleeswaran Ellagic Acid normalizes mitochondrial outer membrane permeabilization and attenuates inflammation-mediated cell proliferation in experimental liver cancer Appl. Biochem. Biotechnol. 173 2014 2254 2266 10.1007/s12010-014-1031-y
307. T. Bender, and J.-C. Martinou Where killers meet - permeabilization of the outer mitochondrial membrane during apoptosis Cold Spring Harb. Perspect. Biol. 5 2013 a011106 10.1101/cshperspect.a011106
308. V. Nikoletopoulou, M. Markaki, K. Palikaras, and N. Tavernarakis Crosstalk between apoptosis, necrosis and autophagy Biochim. Biophys. Acta 1833 2013 3448 3459 10.1016/j.bbamcr.2013.06.001
309. D.W. Stacey Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells Curr. Opin. Cell Biol. 15 2003 158 163 10.1016/S0955-0674(03)00008-5
310. F. Grizzi, B. Franceschini, and N. Gagliano Mast cell density, hepatic stellate cell activation and TGF-b 1 transcripts in the aging Sprague-Dawley rat during early acute liver injury Toxicol. Pathol. 31 2003 173 178 10.1080/01926230390183643
311. G. Lorusso, and C. Rüegg The tumor microenvironment and its contribution to tumor evolution toward metastasis Histochem. Cell Biol. 130 2008 1091 1103 10.1007/s00418-008-0530-8
312. H.W. Verspaget, J.P. Kuyvenhoven, C.F.M. Sier, and B. van Hoek Matrix metalloproteinases in chronic liverdisease and liver transplantation U. Lendeckel, N.M. Hopper, Proteases in Gastrointestinal Tissues 2006 Springer Netherlands 209 234
313. A. Takagi, K. Sai, and T. Umemura Inhibitory effects of vitamin E and ellagic acid on 8-hydroxy-deoxyguanosine formation in liver nuclear DNA of rats treated with 2-nitropropane Cancer Lett. 91 1995 139 144
314. H. Tsuda, N. Uehara, and Y. Iwahori Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat Jpn. J. Cancer Res. 85 1994 1214 1219
315. J.C. Tharappel, H. Lehmler, and C. Srinivasan Effect of antioxidant phytochemicals on the hepatic tumor promoting activity of 3,3′,4,4′-tetrachlorobiphenyl (PCB-77) Food Chem. Toxicol. 46 2008 3467 3474 10.1016/j.fct.2008.08.023
316. K. Akagi, M. Hirose, and T. Hoshiya Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model Cancer Lett. 94 1995 113 121 10.1016/0304-3835(95)03833-I
317. M. Marra, I.M. Sordelli, and A. Lombardi Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview J. Transl. Med. 9 2011 171 10.1186/1479-5876-9-171
318. A. Arzumanyan, HMGP.V. Reis, and M.A. Feitelson Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma Nat. Rev. Cancer 13 2013 123 135 10.1038/nrc3449
319. T.M. Block, A.S. Mehta, C.J. Fimmel, and R. Jordan Molecular viral oncology of hepatocellular carcinoma Oncogene 22 2003 5093 5107 10.1038/sj.onc.1206557
320. S. Locarnini, and F. Zoulim Molecular genetics of HBV infection Antivir. Ther. 15 2010 3 14 10.3851/IMP1619
321. C. Trépo, H.L.Y. Chan, and A. Lok Hepatitis B virus infection Lancet 384 2014 2053 2063 10.1016/S0140-6736(14)60220-8
322. S. Schädler, and E. Hildt HBV life cycle: entry and morphogenesis Viruses 1 2009 185 209 10.3390/v1020185
323. R.K. Pathak, M. Baunthiyal, G. Taj, and A. Kumar Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer Bioinformation 10 2014 428 435
324. M.J. Bouchard, L. Wang, and R.J. Schneider Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication J. Virol. 80 2006 4406 4414 10.1128/JVI.80.9.4406
325. M.S. Shin, E.H. Kang, and Y.I. Lee A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes Antiviral Res. 67 2005 163 168
326. J. Li, H. Huang, and W. Zhou Anti-hepatitis B virus activities of Geranium carolinianum L. extracts and identification of the active components Biol. Pharm. Bull. 31 2008 743 747
327. E.H. Kang, T.Y. Kown, and G.T. Oh The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen Antiviral Res. 72 2006 100 106
328. A. Wohnsland, W.P. Hofmann, and C. Sarrazin Viral determinants of resistance to treatment in patients with hepatitis C Clin. Microbiol. Rev. 20 2007 23 38 10.1128/CMR.00010-06
329. E.R. Feeney, and R.T. Chung Antiviral treatment of hepatitis C BMJ 349 2014 g3308 10.1136/bmj.g3308
330. J. Dubuisson, and F.-L. Cosset Virology and cell biology of the hepatitis C virus life cycle - an update J. Hepatol. 61 2014 S3 S13 10.1016/j.jhep.2014.06.031
331. C.T. Jones, C.L. Murray, and D.K. Eastman Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus J. Virol. 81 2007 8374 8383 10.1128/JVI.00690-07
332. B.U. Reddy, R. Mullick, and A. Kumar Small molecule inhibitors of HCV replication from Pomegranate Sci. Rep. 4 2014 1 10 10.1038/srep05411
333. O.S. Ajala, A. Jukov, and C.-M. Ma Hepatitis C virus inhibitory hydrolysable tannins from the fruits of Terminalia chebula Fitoterapia 99 2014 117 123 10.1016/j.fitote.2014.09.014
334. M. Falsaperla, G. Morgia, and A. Tartarone Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate Eur. Urol. 47 2005 449 454 10.1016/j.eururo.2004.12.001 discussion 454-455
335. A.J. Pantuck, J.T. Leppert, and N. Zomorodian Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer Clin. Cancer Res. 12 2006 4018 4026 10.1158/1078-0432.CCR-05-2290
336. A. Dahl, M. Yatskayer, S. Raab, and C. Oresajo Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone J. Drugs Dermatol. 12 2013 52 58
337. I. Ertam, B. Mutlu, and I. Unal Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study J. Dermatol. 35 2008 570 574 10.1111/j.1346-8138.2008.00522.x
338. K. Kasai, M. Yoshimura, and T. Koga Effects of oral administration of ellagic acid-rich pomegranate extract on ultraviolet-induced pigmentation in the human skin J. Nutr. Sci. Vitaminol. 52 2006 383 388
339. S. Kim, M.W. Gaber, and J.A. Zawaski The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial Biomaterials 30 2009 4743 4751 10.1016/j.biomaterials.2009.05.010
340. S. Kim, S.K. Nishimoto, and J.D. Bumgardner A chitosan/beta-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer Biomaterials 31 2010 4157 4166 10.1016/j.biomaterials.2010.01.139
341. S. Kim, Y. Liu, and M.W. Gaber Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells J. Biomed. Mater. Res. B: Appl. Bioomater. 90 2009 145 155 10.1002/jbm.b.31266
342. V. Arulmozhi, K. Pandian, and S. Mirunalini Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB) Colloids Surf. B 110 2013 313 320 10.1016/j.colsurfb.2013.03.039
343. L. Gopalakrishnan, L.N. Ramana, S. Sethuraman, and U.M. Krishnan Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent Carbohydr. Polym. 111 2014 215 221 10.1016/j.carbpol.2014.03.093
344. I. Bala, V. Bhardwaj, and S. Hariharan Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration J. Drug Target. 14 2006 27 34 10.1080/10611860600565987
345. V.B. Junyaprasert, P. Singhsa, and J. Suksiriworapong Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid Int. J. Pharm. 423 2012 303 311 10.1016/j.ijpharm.2011.11.032
346. Y.I. Jeong, Yv.R. Prasad, and T. Ohno Application of Eudragit P-4135F for the delivery of ellagic acid to the rat lower small intestine J. Pharm. Pharmacol. 53 2001 1079 1085 10.1211/0022357011776469
347. S. Corbett, J. Daniel, and R. Drayton Evaluation of the anti-inflammatory effects of ellagic acid J. Perianesthesia Nurs. 25 2010 214 220 10.1016/j.jopan.2010.05.011
348. K. Kong, S. Mat-Junit, and A. Ismail Polyphenols in Barringtonia racemosa and their protection against oxidation of LDL, serum and haemoglobin Food Chem. 146 2014 85 93 10.1016/j.foodchem.2013.09.012
349. L.C. Porto, J. da Silva, A. Ferraz, and B. de Evaluation of acute and subacute toxicity and mutagenic activity of the aqueous extract of pecan shells [Carya illinoinensis (Wangenh.) K. Koch] Food Chem. Toxicol. 59 2013 579 585 10.1016/j.fct.2013.06.048
350. L.A. De La Rosa, E. Alvarez-Parrilla, and F. Shahidi Phenolic compounds and antioxidant activity of kernels and shells of Mexican pecan (Carya illinoinensis) J. Agric. Food Chem. 59 2011 152 162 10.1021/jf1034306
351. M.-C. Garcia-Alvarez, I. Moussa, and P. Njomnang Soh Both plants Sebastiania chamaelea from Niger and Chrozophora senegalensis from Senegal used in African traditional medicine in malaria treatment share a same active principle J. Ethnopharmacol. 149 2013 676 684 10.1016/j.jep.2013.07.024
352. N. Orhan, M. Aslan, M. Süküroʇlu, and D. Deliorman Orhan In vivo and in vitro antidiabetic effect of Cistus laurifolius L. and detection of major phenolic compounds by UPLC-TOF-MS analysis J. Ethnopharmacol. 146 2013 859 865 10.1016/j.jep.2013.02.016
353. S.K. Sadhu, E. Okuyama, and H. Fujimoto Prostaglandin inhibitory and antioxidant components of Cistus laurifolius, a Turkish medicinal plant J. Ethnopharmacol. 108 2006 371 378 10.1016/j.jep.2006.05.024
354. F. Ferreres, C. Grosso, and A. Gil-Izquierdo Ellagic acid and derivatives from Cochlospermum angolensis Welw, Extracts: HPLC-DAD-ESI/MS(n) profiling, quantification and in vitro anti-depressant, anti-cholinesterase and anti-oxidant activities Phytochem. Anal. 24 2013 534 540 10.1002/pca.2429
355. A. Srivastava, L. Jagan Mohan Rao, and T. Shivanandappa Isolation of ellagic acid from the aqueous extract of the roots of Decalepis hamiltonii: antioxidant activity and cytoprotective effect Food Chem. 103 2007 224 233 10.1016/j.foodchem.2006.08.010
356. P. Krishnappa, K. Venkatarangaiah, and Venkatesh Antioxidant and prophylactic effects of Delonix elata L., stem bark extracts, and flavonoid isolated quercetin against carbon tetrachloride-induced hepatotoxicity in rats Biomed. Res. Int. 2014 2014 507851 10.1155/2014/507851
357. N. Rangkadilok, S. Tongchusak, and R. Boonhok In vitro antifungal activities of longan (Dimocarpus longan Lour.) seed extract Fitoterapia 83 2012 545 553 10.1016/j.fitote.2011.12.023
358. Y. Sudjaroen, W.E. Hull, and G. Erben Isolation and characterization of ellagitannins as the major polyphenolic components of Longan (Dimocarpus longan Lour) seeds Phytochemistry 77 2012 226 237 10.1016/j.phytochem.2011.12.008
359. H.C. Tseng, W.T. Wu, H.S. Huang, and M.C. Wu Antimicrobial activities of various fractions of longan (Dimocarpus longan Lour, Fen Ke) seed extract Int. J. Food Sci. Nutr. 65 2014 589 593 10.3109/09637486.2014.886181
360. W. Luo, M. Zhao, and B. Yang Identification of bioactive compounds in Phyllenthus emblica L. fruit and their free radical scavenging activities Food Chem. 114 2009 499 504
361. M. Krishnaveni, and S. Mirunalini Chemopreventive efficacy of Phyllanthus emblica L. (amla) fruit extract on 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis - a dose-response study Environ. Toxicol. Pharmacol. 34 2012 801 810 10.1016/j.etap.2012.09.006
362. J.J. D'souza, P.P. D'souza, and F. Fazal Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: active constituents and modes of action Food Funct. 5 2014 635 644 10.1039/c3fo60366k
363. K.R. Thilakchand, R.T. Mathai, and P. Simon Hepatoprotective properties of the Indian gooseberry (Emblica officinalis Gaertn): a review Food Funct. 4 2013 1431 1441 10.1039/c3fo60237k
364. S.V. Nampoothiri, A. Prathapan, and O.L. Cherian In vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes Food Chem. Toxicol. 49 2011 125 131 10.1016/j.fct.2010.10.006
365. M.S. Baliga, and J.J. Dsouza Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer Eur. J. Cancer Prev. 20 2011 225 239 10.1097/CEJ.0b013e32834473f4
366. A. Ihantola-Vormisto, J. Summanen, and H. Kankaanranta Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica Planta Med. 63 1997 518 524 10.1055/s-2006-957754
367. G. Vázquez, J. Santos, and M.S. Freire Extraction of antioxidants from eucalyptus (Eucalyptus globulus) bark Wood Sci. Technol. 46 2012 443 457
368. Q.-M. Guo, and X.-W. Yang A new ellagic acid derivative from the fruits of Eucalyptus globulus Labill Pharmazie 60 2005 708 710
369. I.F. Almeida, E. Fernandes, and J.L.F.C. Lima Oxygen and nitrogen reactive species are effectively scavenged by Eucalyptus globulus leaf water extract J. Med. Food 12 2009 175 183 10.1089/jmf.2008.0046
370. A.R. Verma, M. Vijayakumar, C.V. Rao, and C.S. Mathela In vitro and in vivo antioxidant properties and DNA damage protective activity of green fruit of Ficus glomerata Food Chem. Toxicol. 48 2010 704 709 10.1016/j.fct.2009.11.052
371. C.V. Rao, A.R. Verma, M. Vijayakumar, and S. Rastogi Gastroprotective effect of standardized extract of Ficus glomerata fruit on experimental gastric ulcers in rats J. Ethnopharmacol. 115 2008 323 326
372. Q.Y. Wu, Y. Zhou, and X. Jin Chromatographic fingerprint and the simultaneous determination of five bioactive components of Geranium carolinianum L. water extract by high performance liquid chromatography Int. J. Mol. Sci. 12 2011 8740 8749 10.3390/ijms12128740
373. A. Owczarek, and J. Gudej Investigation into biologically active constituents of Geum rivale L Acta Pol. Pharm. 70 2013 111 114
374. J. Sun, and P. Chen UHPLC/HRMS analysis of African Mango (Irvingia gabonensis) seeds, extract and related dietary supplements J. Agric. Food Chem. 60 2013 8703 8709 10.1021/jf302703u
375. Nutan, M. Modi, and T. Goel Ellagic acid & gallic acid from Lagerstroemia speciosa L. inhibit HIV-1 infection through inhibition of HIV-1 protease & reverse transcriptase activity Indian J. Med. Res. 137 2013 540 548
376. T. Unno, A. Sugimoto, and T. Kakuda Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers J. Ethnopharmacol. 93 2004 391 395 10.1016/j.jep.2004.04.012
377. N. Bai, K. He, and M. Roller Active compounds from Lagerstroemia speciosa, insulin-like glucose uptake-stimulatory/inhibitory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells J. Agric. Food Chem. 56 2008 11668 11674 10.1021/jf802152z
378. F. Liu, J. Kim, and Y. Li An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells J. Nutr. 131 2001 2242 2247
379. A.O. Da Silva, A. Damaceno Alves, and D.A.T.D. Almeida Evaluation of anti-inflammatory and mechanism of action of extract of Macrosiphonia longiflora (Desf.) Müll. Arg. J. Ethnopharmacol. 154 2014 319 329 10.1016/j.jep.2014.03.017
380. J.A. Manthey, and P. Perkins Veazie Influences of harvest date and location on the levels of β-carotene, ascorbic acid, total phenols, the in vitro antioxidant capacity, and phenolic profiles of five commercial varieties of mango (Mangifera indica L.) J. Agric. Food Chem. 57 2009 10825 10830 10.1021/jf902606h
381. A.R. Verma, M. Vijayakumar, C.S. Mathela, and C.V. Rao In vitro and in vivo antioxidant properties of different fractions of Moringa oleifera leaves Food Chem. Toxicol. 47 2009 2196 2201 10.1016/j.fct.2009.06.005
382. B.N. Singh, B.R. Singh, and R.L. Singh Oxidative DNA damage protective activity, antioxidant and anti-quorum sensing potentials of Moringa oleifera Food Chem. Toxicol. 47 2009 1109 1116 10.1016/j.fct.2009.01.034
383. M. Sinha, D.K. Das, and S. Datta Amelioration of ionizing radiation induced lipid peroxidation in mouse liver by Moringa oleifera Lam. leaf extract Indian J. Exp. Biol. 50 2012 209 215
384. D. Fracassetti, C. Costa, L. Moulay, and F.A. Tomás-Barberán Ellagic acid derivatives, ellagitannins, proanthocyanidins and other phenolics, vitamin C and antioxidant capacity of two powder products from camu-camu fruit (Myrciaria dubia) Food Chem. 139 2013 578 588 10.1016/j.foodchem.2013.01.121
385. H.-T. Xiao, S.-W. Tsang, and H.-Y. Qin A bioactivity-guided study on the anti-diarrheal activity of Polygonum chinense Linn J. Ethnopharmacol. 149 2013 499 505 10.1016/j.jep.2013.07.007
386. G. Flores, K. Dastmalchi, and S.-B. Wu Phenolic-rich extract from the Costa Rican guava (Psidium friedrichsthalianum) pulp with antioxidant and anti-inflammatory activity. Potential for COPD therapy Food Chem. 141 2013 889 895 10.1016/j.foodchem.2013.03.025
387. W. Elfalleh, N. Tlili, and N. Nasri Antioxidant capacities of phenolic compounds and tocopherols from Tunisian pomegranate (Punica granatum) fruits J. Food Sci. 76 2011 C707 C713 10.1111/j.1750-3841.2011.02179.x
388. F. Hadrich, S. Cher, Y.T. Gargouri, and S. Adel Antioxidant and lipase inhibitory activities and essential oil composition of pomegranate peel extracts J. Oleo Sci. 63 2014 515 525 10.5650/jos.ess13163
389. M. Navarro, M. Amigo-Benavent, and M. Mesias An aqueous pomegranate seed extract ameliorates oxidative stress of human hepatoma HepG2 cells J. Sci. Food Agric. 94 2014 1622 1627 10.1002/jsfa.6469
390. S. Banihani, S. Swedan, and Z. Alguraan Pomegranate and type 2 diabetes Nutr. Res. 33 2013 341 348 10.1016/j.nutres.2013.03.003
391. D. Bakkiyaraj, J.R. Nandhini, B. Malathy, and S.K. Pandian The anti-biofilm potential of pomegranate (Punica granatum L.) extract against human bacterial and fungal pathogens Biofouling 29 2013 929 937 10.1080/08927014.2013.820825
392. L. Wang, and M. Martins-green Pomegranate and its components as alternative treatment for prostate cancer Int. J. Mol. Sci. 15 2014 14949 14966 10.3390/ijms150914949
393. L.B. Saad, K.K. Hwi, and T. Quah Evaluation of the antinociceptive effect of the ethanolic extract of Punica granatum Afr. J. Tradit. Complement Altern. Med. 11 2014 228 233
394. A. Rocha, L. Wang, M. Penichet, and M. Martins-Green Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer Breast Cancer Res. Treat. 136 2012 647 658 10.1007/s10549-012-2264-5
395. J. Gao, C. Sun, and J. Yang Evaluation of the hepatoprotective and antioxidant activities of Rubus parvifolius L J. Zhejiang Univ. B 12 2011 135 142 10.1631/jzus.B1000117
396. A. Mahfoudhi, F.P. Prencipe, Z. Mighri, and F. Pellati Metabolite profiling of polyphenols in the Tunisian plant Tamarix aphylla (L.) Karst J. Pharm. Biomed. Anal. 99C 2014 97 105 10.1016/j.jpba.2014.07.013
397. F. Pellati, R. Bruni, and D. Righi Metabolite profiling of polyphenols in a Terminalia chebula Retzius ayurvedic decoction and evaluation of its chemopreventive activity J. Ethnopharmacol. 147 2013 277 285 10.1016/j.jep.2013.02.025
398. S. Sarabhai, P. Sharma, and N. Capalash Ellagic acid derivatives from Terminalia chebula Retz. downregulate the expression of quorum sensing genes to attenuate Pseudomonas aeruginosa PAO1 virulence PLoS ONE 8 2013 1 11 10.1371/journal.pone.0053441
399. B. Pfundstein, S.K. El Desouky, and W.E. Hull Polyphenolic compounds in the fruits of Egyptian medicinal plants (Terminalia bellerica, Terminalia chebula and Terminalia horrida): characterization, quantitation and determination of antioxidant capacities Phytochemistry 71 2010 1132 1148 10.1016/j.phytochem.2010.03.018
400. A. Saleem, M. Husheem, P. Härkönen, and K. Pihlaja Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit J. Ethnopharmacol. 81 2002 327 336 10.1016/S0378-8741(02)00099-5
401. S.S. Ambrose, P. Solaraij, and A. Subramoniam Hepatoprotective activity of active fractions of Thespesia lampas Dalz and Gibs (Malvaceae) J. Pharmacol. Pharmacother. 3 2012 326 328 10.4103/0976-500X.103690
402. B. Sangameswaran, B.R. Balakrishnan, C. Deshraj, and B. Jayakar In vitro antioxidant activity of roots of Thespesia lampas Dalz and Gibs Pak. J. Pharm. Sci. 22 2009 368 372
403. S.H. Wang, M.Y. Kao, and S.C. Wu Oral administration of Trapa taiwanensis Nakai fruit skin extracts conferring hepatoprotection from CCl4-caused injury J. Agric. Food Chem. 59 2011 3686 3692 10.1021/jf1048386
404. Q. You, F. Chen, and X. Wang Analysis of phenolic composition of Noble muscadine (Vitis rotundifolia) by HPLC-MS and the relationship to its antioxidant capacity J. Food Sci. 77 2012 C1115 C1123 10.1111/j.1750-3841.2012.02888.x
405. A.K. Sandhu, and L. Gu Antioxidant capacity, phenolic content, and profiling of phenolic compounds in the seeds, skin, and pulp of vitis rotundifolia (Muscadine Grapes) as determined by HPLC-DAD-ESI-MS(n) J. Agric. Food Chem. 58 2010 4681 4692 10.1021/jf904211q
406. S.U. Mertens-Talcott, J.H. Lee, S.S. Percival, and S.T. Talcott Induction of cell death in Caco-2 human colon carcinoma cells by ellagic acid rich fractions from muscadine grapes (Vitis rotundifolia) J. Agric. Food Chem. 54 2006 5336 5343
407. M. Hiralal Ghante, K.P. Bhusari, N.J. Duragkar, and N.B. Ghiware Pharmacological evaluation for anti-asthmatic and anti-inflammatory potential of Woodfordia fruticosa flower extracts Pharm. Biol. 52 2014 804 813 10.3109/13880209.2013.869232
408. D. Dubey, R. Patnaik, G. Ghosh, and R.N. Padhy In vitro antibacterial activity, gas chromatography e mass spectrometry analysis of Woodfordia fruticosa Kurz. leaf extract and host toxicity testing with in vitro cultured lymphocytes from human umbilical cord blood Osong Public Heal. Res. Perspect. 5 2014 298 312 10.1016/j.phrp.2014.08.001
409. N. Devipriya, M. Srinivasan, A.R. Sudheer, and V.P. Menon Effect of ellagic acid, a natural polyphenol, on alcohol-induced prooxidant and antioxidant imbalance: a drug dose dependent study Singapore Med. J. 48 2007 311 318
410. K.C. Thresiamma, and R. Kuttan Inhibition of liver fibrosis by ellagic acid Indian J. Physiol. Pharmacol. 40 1996 363 366
411. R.H. Mahmoud, and N.M. El-Fateh The chemopreventive role of ellagic acid on hepatocarcinomic rats Afr. J. Biol. Sci. 7 2011 105 119